- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT02596607
Study of the Performance of Stroke Management in the Rhône Area (STROKE 69)
Study of the Performance of Acute Stroke Management in the Rhône Area After Implementation of a Multi-action Program
Acute stroke management represents a true medical emergency that requires prompt diagnosis and urgent treatment. However, only a small percentage of patients access to thrombolysis on time. Various actions have been implemented since 2006 in the Rhone area as part of research projects and of the 2010-2014 national stroke action plan: training of health professionals involved in the stroke management, increase of public awareness through sensibilization campaigns, implementation of telemedicine and increase of the number of hospital beds dedicated to stroke (stroke units beds).
The main objective of the STROKE 69 study is to assess the impact of these actions on intra-hospital acute stroke management times in the Rhône area. The secondary objectives are to assess the impact of these actions on the rate and place of thrombolysis, the rate of post- thrombolysis hemorrhage, the rate of thrombectomies, mortality in the acute phase, at 3 and 12 months, the level of disability at 3 and 12 months, pre-hospital times, the number of calls to SAMU centre 15 (French mobile emergency medical services, equivalent to 911) and management channels.
The investigator will perform a prospective cohort study between 06/11/2015 and 06/06/2016 and data will be compared to data collected in a previous cohorts study, the AVC-69 cohort study (Porthault Chatard et al, Int J Stroke. 2012 Oct;7(7):E13), between 06/11/2006 and 06/06/2007, before the implementation of the actions in the Rhône area.
The cohort will be constituted of all consecutive patients treated for a stroke suspicion by the Rhône SAMU centre 15, or in one of the emergency unit or stroke unit of the Rhône area, and presenting a symptom-onset (the last time the patient was seen without deficit) less than 24 hours.
After collecting data in the acute phase, patients with a confirmed diagnosis of stroke or transient ischemic attack (TIA) will be followed for 12 months after their inclusion by telephone calls at 3 and 12 months to assess the level of disability and mortality.
AVC 69 study allowed us to include 1306 patients between 2006 to 2007, the investigator plan to include at least 1300 patients in the STROKE 69 cohort with approximately 1000 confirmed strokes or TIAs.
Aperçu de l'étude
Statut
Les conditions
Type d'étude
Inscription (Réel)
Contacts et emplacements
Lieux d'étude
-
-
-
Bron, France, 69500
- Department of stroke unit - Hospices Civils de Lyon
-
Bron, France
- Hôpital Desgenettes
-
Lyon, France
- Hôpital de la Croix Rousse
-
Lyon, France
- Hôpital St Joseph St Luc
-
Lyon, France
- Urgences et Réanimation Médicale et SAMU, Hôpital Edouard Herriot
-
Pierre-Bénite, France
- Centre Hospitalier Lyon Sud
-
Villefranche-sur-Saône, France
- CH Villefranche
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- Consecutive patients treated for a stroke suspicion at the acute phase ,
- with symptom onset (the last time the patient was seen without deficit ) less than 24 hours,
- Managed by the SAMU centre 15, in one of the emergency unit or stroke unit of the Rhône area
- Regardless of their geographical origin
Exclusion Criteria:
- Age under 18 years
- Symptom onset exceeding 24 hours
- Stroke during hospitalization
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Intra -hospital management times
Délai: 24h
|
|
24h
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Assessment of the overall impact of actions on patients management
Délai: 24h
|
Proportion of patients thrombolysed, proportion of cerebral hemorrhage after thrombolysis, proportion of patients treated by thrombectomy
|
24h
|
Assessment of the impact of public campaigns
Délai: 24h
|
Pre-hospital time: symptoms onset- hospital admission time (admission in stroke unit or emergency unit), time from symptom onset to call to SAMU centre 15
|
24h
|
Assessment of the impact of the increase of stroke unit beds
Délai: 48h
|
Proportion of patients managed in stroke unit at acute phase
|
48h
|
Assessment of the impact of training of SAMU centre 15 professionals and firefighters on stroke detection
Délai: 24h
|
Proportion of patients managed by fast-track (direct admission in stroke unit after call to SAMU centre 15), proportion of patients managed by the SAMU centre 15
|
24h
|
Assessment of the impact of the implementation of telemedicine
Délai: 24h
|
Proportion of patients thrombolysed in emergency unit via telemedicine / stroke unit / critical care unit )
|
24h
|
Assessment of the impact of the actions on the prognosis of patients
Délai: 12 months
|
Proportion of patients who died during the initial hospitalization, proportion of patients who died at 3 and 12 months, proportion of patients with disabilities at 3 and 12 months evaluated by the Modified Rankin Scale and by the Barthel Index among patients with a confirmed diagnosis of stroke or TIA
|
12 months
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Laurent DEREX, MD, Hospices Civils De Lyon
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 69HCL15_0076
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .